Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 3.33
-3.76 %
$ 58.7 M
Market Cap
-3.54
P/E
Price Target
Average
62.16%
Revenue Forecast
Estimate
21.22%
EBIT
Estimate
--26.09%
Net Income
Estimate
52.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exagen Inc.
Wall Street analysts predict an average 1-year price target for XGN of $5.4 , with forecasts ranging from
a
low of
$5 to a high of $7 .
XGN Lowest Price Target
Wall Street Target
5 USD
50.15%
XGN Average Price Target
Wall Street Target
5.4 USD
62.16%
XGN Highest Price Target
Wall Street Target
7 USD
110.21%
REVENUE FORECAST
Revenue Forecast Chart XGN
EBIT FORECAST
EBIT Forecast Chart XGN
NET INCOME FORECAST
Net Income Chart XGN